MedPageToday
MedPage Today) — MADRID — Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced recurrences without much…
Read More
Year of Low-Dose DOAC Slashes Recurrence After Provoked VTE
MedPage Today) — MADRID — Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced recurrences without much…